International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 1 , Pages 29-37 , 1 May 2009

An Exploratory Study Into the Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging or Perfusion Computed Tomography for Detection of Intratumoral Hypoxia in Head-and-Neck Cancer

  • Kate Newbold, M.D.

      Affiliations

    • The Royal Marsden Hospital, Sutton, United Kingdom
    • Corresponding Author InformationReprint requests to: Kate Newbold, M.D., The Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, United Kingdom. Tel: (00) 44-208-661-3638; Fax: (00) 44-208-915-6719
    • ,
  • Isabel Castellano, Ph.D.

      Affiliations

    • Institute of Cancer Research, London, United Kingdom
    • ,
  • Elizabeth Charles-Edwards, M.Sc.

      Affiliations

    • Institute of Cancer Research, Sutton, Surrey, United Kingdom
    • ,
  • Dorothy Mears, D.C.R.

      Affiliations

    • The Royal Marsden Hospital, Sutton, United Kingdom
    • ,
  • Aslam Sohaib, F.R.C.R.

      Affiliations

    • The Royal Marsden Hospital, Sutton, United Kingdom
    • ,
  • Martin Leach, Ph.D.

      Affiliations

    • Institute of Cancer Research, Sutton, Surrey, United Kingdom
    • ,
  • Peter Rhys-Evans, F.R.C.S.

      Affiliations

    • The Royal Marsden Hospital, London, United Kingdom
    • ,
  • Peter Clarke, F.R.C.S.

      Affiliations

    • The Royal Marsden Hospital, London, United Kingdom
    • ,
  • Cyril Fisher, M.D.

      Affiliations

    • The Royal Marsden Hospital, London, United Kingdom
    • ,
  • Kevin Harrington, Ph.D.

      Affiliations

    • Institute of Cancer Research, London, United Kingdom
    • The Royal Marsden Hospital, London, United Kingdom
    • ,
  • Christopher Nutting, M.D.

      Affiliations

    • The Royal Marsden Hospital, London, United Kingdom

Received 27 March 2008 ,Revised 21 July 2008 ,Accepted 22 July 2008.

References 

  1. Vaupel P, Kelleher DK, Thews O. Modulation of tumor oxygenation. Int J Radiat Oncol Biol Phys. 1998;42:843–848
  2. Brizel DM, Sibley GS, Prosnitz LR, et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997;38:285–289
  3. Stadler P, Becker A, Feldmann HJ, et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;44:749–754
  4. Gatenby RA, Kessler HB, Rosenblum JS, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 1988;14:831–838
  5. Dewhirst MW, Ong ET, Braun RD, et al. Quantification of longitudinal tissue Po2 gradients in window chamber tumours: Impact on tumour hypoxia. Br J Cancer. 1999;79:1717–1722
  6. Secomb TW, Hsu R, Braun RD, et al. Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels. Adv Exp Med Biol. 1998;454:629–634
  7. Wheeler RH, Ziessman HA, Medvec BR, et al. Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer. Cancer Res. 1986;46:4200–4204
  8. Raleigh JA, Chou SC, Arteel GE, et al. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res. 1999;151:580–589
  9. Vordermark D, Kaffer A, Riedl S, et al. Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells. Int J Radiat Oncol Biol Phys. 2005;61:1197–1207
  10. Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin Cancer Res. 2001;7:3399–3403
  11. Lal A, Peters H, St Croix B, et al. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst. 2001;93:1337–1343
  12. Parker GJ, Suckling J, Tanner SF, et al. MRIW: Parametric analysis software for contrast-enhanced dynamic MR imaging in cancer. Radiographics. 1998;18:497–506
  13. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223–232
  14. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR. 1984;16:167–172
  15. Cron GO, Santyr G, Kelcz F. Accurate and rapid quantitative dynamic contrast-enhanced breast MR imaging using spoiled gradient-recalled echoes and bookend T(1) measurements. Magn Reson Med. 1999;42:746–753
  16. Fritz-Hansen T, Rostrup E, Larsson HB, et al. Measurement of the arterial concentration of Gd-DTPA using MRI: A step toward quantitative perfusion imaging. Magn Reson Med. 1996;36:225–231
  17. Charles-Edwards E, Newbold K, Castellano I, et al. Arterial input functions from sub-second MR and CT imaging: Quality and accuracy. [Abstract] Proc Int Soc Magn Reson Med 14. 2006;3496
  18. Raleigh JA, Chou SC, Bono EL, et al. Semiquantitative immunohistochemical analysis for hypoxia in human tumors. Int J Radiat Oncol Biol Phys. 2001;49:569–574
  19. Hoskin PJ, Sibtain A, Daley FM, et al. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: Relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer. 2003;89:1290–1297
  20. Janssen HL. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumours. Int J Radiat Oncol Biol Phys. 2002;54:1537–1549
  21. Kaanders JH, Wijffels KI, Marres HA, et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res. 2002;62:7066–7074
  22. Nordsmark M, Loncaster J, Aquino-Parsons C, et al. Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. Radiother Oncol. 2003;67:35–44
  23. Nordsmark M, Loncaster J, Aquino-Parsons C, et al. The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: A prospective international multi-center study. Radiother Oncol. 2006;80:123–131
  24. Hoskin PJ, Saunders MI, Goodchild K, et al. Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br J Radiol. 1999;72:1093–1098
  25. Cooper RA, Carrington BM, Loncaster JA, et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol. 2000;57:53–59
  26. Loncaster JA, Harris AL, Davidson SE, et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 2001;61:6394–6399
  27. Devries AF, Griebel J, Kremser C, et al. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res. 2001;61:2513–2516
  28. Haider MA, Milosevic M, Fyles A, et al. Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. Int J Radiat Oncol Biol Phys. 2005;62:1100–1107
  29. Hermans R, Meijerink M, Van den Bogaert W, et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57:1351–1356
  30. Gandhi D, Hoeffner EG, Carlos RC, et al. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results. J Comput Assist Tomogr. 2003;27:687–693
  31. De Schutter H, Landuyt W, Verbeken E, et al. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy. BMC Cancer. 2005;5:42

 Dr. Newbold was funded by a Royal College of Radiologists/BUPA Research Fellowship and The Royal Marsden Hospital General Clinical Research Fund.

 Conflict of interest: none.

PII: S0360-3016(08)03179-9

doi: 10.1016/j.ijrobp.2008.07.039

International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 1 , Pages 29-37 , 1 May 2009

Article Tools

* Image Usage & Resolution